breakin news In Russia, the term for the release of the drug from COVID-19 to the market will be reduced lastminute news
Short link 03:54 In Russia, the drug release time from the Favipiravir coronavirus, which is currently undergoing clinical trials, will be reduced.It is reported by RIA Novosti with reference to th…
In Russia, the drug release time from the Favipiravir coronavirus, which is currently undergoing clinical trials, will be reduced.
It is reported by RIA Novosti with reference to the press service of the Ministry of Health.
It is noted that so far this drug is not registered in Russia
“The positive results of a limited clinical research program will allow the initiation of a state registration procedure with the establishment of post-registration measures regarding, inter alia, the appointment of studies in the post-registration period,” indicated in the text.
The Ministry of Health summarized that this would significantly reduce the time needed to bring the drug to the market.
Earlier, the Minister of Health of Russia Mikhail Murashko said the first vaccine result from coronavirus may appear in late July....
breakin news Michael White, un vetéran américain détenu en Iran, a quitté le pays après sa libération">